ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
With Merck Footing the $200M Bill, Moderna Launches mRNA Cancer Vaccine Clinical Trial
November 17, 2017Moderna Therapeutics announced that it has dosed its first patient in a Phase I trial of mRNA-4157, a messenger RNA (mRNA)-based personalized cancer vaccine. -
Lilly, CureVac pen $1.8B mRNA cancer vaccine deal
October 19, 2017Lilly is making a $50 million upfront payment and €45 million equity investment to get the deal up and running. -
AstraZeneca strikes mRNA-based partnership in respiratory disease
August 23, 2017AstraZeneca and MedImmune, the company’s biologics research arm, have forged a five year research partnership with mRNA-based pulmonary disease specialist Ethris to leverage the latter’s proprietary SNIM RNA technology in the...
Pharma Sources Insight January 2025
